Live Breaking News & Updates on கார்டினல் ஹிக்கரி க்ரீக்|Page 7

Stay updated with breaking news from கார்டினல் ஹிக்கரி க்ரீக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cardinal Energy Ltd. Completes Redemption of 8.00% Convertible Debentures


/EIN News/ CALGARY, Alberta, March 11, 2021 (GLOBE NEWSWIRE) Cardinal Energy Ltd. (
Cardinal or the
Company ) (TSX: CJ; CJ.DB.A) announced today that it has completed the previously announced redemption of its 8.00% Convertible Unsecured Subordinated Debentures due December 31, 2022 (the
Debentures ). Prior to the redemption date, Cardinal issued 22,410,000 common shares upon the voluntary conversion of $28,013,000 principal amount of the Debentures representing approximately 99.3% of the outstanding Debentures. The redemption of the remaining $194,000 principal amount of the Debentures was funded through the Company s credit facility. As the majority of the Debentures were converted into common shares, the redemption financing of unsecured subordinated non-convertible debt announced in our February 4, 2021 press release was not completed. The Debentures were delisted today from the Toronto Stock Exchange. ....

Laurence Broos , Shawn Van Spankeren , M Scott Ratushny , Toronto Stock Exchange , Cardinal Energy Ltd , Convertible Unsecured Subordinated Debentures , Toronto Stock , 8 00 , டொராண்டோ ஸ்டாக் பரிமாற்றம் , கார்டினல் ஆற்றல் லிமிடெட் , டொராண்டோ ஸ்டாக் ,

Cardinal Health to sell Cordis medical device business in $1 billion deal


2 Min Read
(Reuters) - Cardinal Health Inc will sell its Cordis medical device business to private equity firm Hellman & Friedman in a deal valued at about $1 billion, the drug distributor said on Friday.
The sale of the unit acquired in 2015 from Johnson & Johnson for $1.9 billion comes as drug distributors look to slim down after a rapid pace of consolidation.
Rival AmerisourceBergen Corp last year decided to shut down its compounding pharmacy business, PharMEDium, after struggling with regulatory hurdles and losses.
“This is the latest example of the drug wholesalers unwinding assets snatched up as the industry looked to consolidate over the past 5 years, with the common trend being buying high and selling lower,” Raymond James analyst Alex Ruscher said of the Cordis deal. ....

United States , Hellman Friedman , Manas Mishra , Sriraj Kalluvila , Mrinalika Roy , Thomson Reuters Trust Principles , Cardinal Health , Cardinal Health Inc , Thomson Reuters Trust , Content Produced In Bangalore , Company News , Divestitures Spin Offs , Health Medicine , Healthcare Trbc Level 1 , Medical Devices Amp Implants Trbc Level 5 , Medical Diagnostic Amp Testing Equipment Trbc Level 5 , Mergers Acquisitions Takeovers , Private Equity Trbc Level 5 , Results Forecasts Warnings , ஒன்றுபட்டது மாநிலங்களில் , நரகத்தில் மனிதன் ப்ரைட்மேன் , மனஸ் மிஸ்ரா , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ப்ரிந்ஸிபல்ஸ் , கார்டினல் ஆரோக்கியம் , கார்டினல் ஆரோக்கியம் இன்க் , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ,